EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
India has a pivotal role in eliminating TB
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
Integration of modern and traditional medicine to facilitate the illness to wellness journey
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
Subscribe To Our Newsletter & Stay Updated